You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PRX-102

Showing 1 - 25 of 446
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fabry Disease Trial (PRX-102 1 mg/kg every 2 weeks, PRX-102 2 mg/kg every 4 weeks)

Not yet recruiting
  • Fabry Disease
  • PRX-102 1 mg/kg every 2 weeks
  • PRX-102 2 mg/kg every 4 weeks
  • (no location specified)
Jan 24, 2023

Fabry Disease Trial in Worldwide (PRX-102 (pegunigalsidase alfa))

Completed
  • Fabry Disease
  • PRX-102 (pegunigalsidase alfa)
  • Gainesville, Florida
  • +6 more
Jan 20, 2022

Fabry Disease Trial in Worldwide (pegunigalsidase alfa)

Enrolling by invitation
  • Fabry Disease
  • pegunigalsidase alfa
  • Birmingham, Alabama
  • +14 more
Feb 14, 2022

Fabry Disease Trial in Worldwide (PRX-102 (pegunigalsidase alfa), agalsidase beta)

Completed
  • Fabry Disease
  • PRX-102 (pegunigalsidase alfa)
  • agalsidase beta
  • Birmingham, Alabama
  • +28 more
Oct 12, 2022

Fabry Disease Trial in Worldwide (Pegunigalsidase alfa)

Completed
  • Fabry Disease
  • Pegunigalsidase alfa
  • Birmingham, Alabama
  • +20 more
Mar 29, 2022

Fabry Disease Trial in Worldwide (pegunigalsidase alfa)

Enrolling by invitation
  • Fabry Disease
  • pegunigalsidase alfa
  • Birmingham, Alabama
  • +28 more
Feb 14, 2022

Fabry Disease Trial in Worldwide (PRX-102)

Completed
Has Results
  • Fabry Disease
  • PRX-102
  • Sacramento, California
  • +13 more
Jan 14, 2020

Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly

Enrolling by invitation
  • Fabry Disease
  • Interview
  • Birmingham, Alabama
  • +11 more
Mar 8, 2022

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Diabetic Foot Infection Trial (TP-102, Placebo)

Not yet recruiting
  • Diabetic Foot Infection
  • TP-102
  • Placebo
  • (no location specified)
Jul 6, 2023

Trifluridine/Tipiracil Plus Bevacizumab Versus

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 11, 2023

Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Sep 8, 2023

Diabetic Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, Placebo)

Recruiting
  • Diabetic Gastroparesis
  • CIN-102 Dose 1
  • +2 more
  • Tucson, Arizona
  • +19 more
Apr 14, 2023

Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,

Completed
  • Rectal Adenocarcinoma
  • +4 more
  • Quality-of-Life Assessment
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jan 3, 2023

Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester

Active, not recruiting
Has Results
  • Cholangiocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
  • Scottsdale, Arizona
  • +1 more
Jan 4, 2023

Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)

Not yet recruiting
  • Colon Cancer
  • Rectal Cancer
  • TAS-102, oxaliplatin, irinotecan with bevacizumab
  • Elizabeth, New Jersey
  • +6 more
Apr 7, 2023

Kidney Diseases, Kidney Injury, Kidney Failure Trial in Suzhou, Xuzhou (MB-102 DMID, MB-102 OMID, MediBeacon Transdermal

Recruiting
  • Kidney Diseases
  • +2 more
  • MB-102 DMID
  • +2 more
  • Suzhou, Jiangsu, China
  • +1 more
Jul 11, 2023

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Kidney Diseases, Kidney Injury, Kidney Failure Trial in Chicago, San Antonio (MB-102, MediBeacon Transdermal Glomerular

Recruiting
  • Kidney Diseases
  • +2 more
  • MB-102
  • MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)
  • Chicago, Illinois
  • +1 more
Mar 22, 2023

Dry Eye Disease Trial in Rush (INV-102, Vehicle)

Recruiting
  • Dry Eye Disease
  • Rush, New York
    iuvo BioScience
Jan 12, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Delayed Pregnancy Loss, Early Pregnancy Loss Trial (CCT-102 A and CCT-102 B)

Not yet recruiting
  • Delayed Pregnancy Loss, Early Pregnancy Loss
  • CCT-102 A and CCT-102 B
  • (no location specified)
Nov 2, 2023

Gastric Cancer, Pancreatic Cancer Trial in Fukuoka-shi (Phase I part, Phase II part)

Recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • Phase I part
  • Phase II part
  • Fukuoka-shi, Fukuoka, Fukuoka, Japan
    Kyushu University Hospital
Jun 24, 2022

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023